Fujian Cosunter Pharmaceutical Co., Ltd. (300436)
Market Open
10 Aug, 06:57
XSHE XSHE Primary ¥
96. 70
-0.18
-0.1858%
¥
16.2B Market Cap
- P/E Ratio
0.4% Div Yield
9.63M Volume
- Eps
¥ 96.88
Previous Close Want to track 300436 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
300436 trading today lower at ¥96.7, a decrease of -0.1858% from yesterday's close, completing a monthly decrease of -9.6684% or -¥10.35. Over the past 12 months, 300436 stock gained 8.6517%.
300436 is not paying dividends to its shareholders.
The last earnings report, released on May 13, 2025, missed the consensus estimates by -0.5379%. On average, the company has fell short of earnings expectations by -0.2965%, based on the last three reports.
Fujian Cosunter Pharmaceutical Co., Ltd. has completed 1 stock splits, with the recent split occurring on Sep 16, 2015.
The company's stock is traded on one exchange.
300436 Chart
People also search for
Fujian Cosunter Pharmaceutical Co., Ltd. (300436) FAQ
What is the stock price today?
The current price is ¥96.70.
On which exchange is it traded?
Fujian Cosunter Pharmaceutical Co., Ltd. is listed on XSHE.
What is its stock symbol?
The ticker symbol is 300436.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.4%.
What is its market cap?
As of today, the market cap is 16.2B.
Has Fujian Cosunter Pharmaceutical Co., Ltd. ever had a stock split?
Fujian Cosunter Pharmaceutical Co., Ltd. had 1 splits and the recent split was on Sep 16, 2015.
Fujian Cosunter Pharmaceutical Co., Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Guoping Li CEO | XSHE Exchange | CNE100001YZ0 ISIN |
| CN Country | 760 Employees | 4 May 2018 Last Dividend | 16 Sep 2015 Last Split | - IPO Date |
Overview
Fujian Cosunter Pharmaceutical Co., Ltd. is a China-based pharmaceutical company established in 2001. The company is dedicated to the research, development, manufacturing, and sales of pharmaceutical products. It caters to a wide range of medical needs, including anti-HBV, liver diseases, digestive and respiratory conditions, cardiovascular issues, and men's health. Headquartered in Fuzhou, China, Fujian Cosunter Pharmaceutical has developed competence in producing quality crude drugs and solid preparation forms such as tablets, capsules, granules, and medicinal teas, making a significant impact in the pharmaceutical industry within China.
Products and Services
- Anti-HBV Medications - Specialized pharmaceuticals developed to combat the hepatitis B virus (HBV), offering patients crucial options for managing this chronic liver infection.
- Liver Disease Treatments - A comprehensive range of products focusing on the prevention, treatment, and management of various liver conditions, underlining the company's commitment to hepatological health.
- Digestive Health Solutions - Products designed to improve gastrointestinal health, addressing issues such as acidity, indigestion, and other digestive disorders.
- Respiratory Medications - A line of pharmaceuticals intended for the treatment of respiratory conditions, aiding in the relief of symptoms associated with diseases like asthma and COPD.
- Cardiovascular Drugs - Medicines aimed at treating and managing cardiovascular diseases, including hypertension and heart failure, to support heart health.
- Men's Health Products - A specialized segment focusing on the treatment of conditions prevalent in men, promoting overall wellbeing and health.
- Crude Drug and Solid Preparation - The company excels in producing raw pharmaceutical materials and finished products in various forms including tablets, capsules, granules, and medicinal teas, catering to diverse patient needs.
Contact Information
Address: Building 16, Phase II, Fuzhou, China, 350003
Phone: 86 591 3826 5199
Website: https://www.cosunter.com
